Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.37 |
| ▸ | HTR2B | P41595 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31277237 | 0.82 | CA2 (0.54) | APPCA12CA1CA2CA7 | |
| SCHEMBL470124 | 0.82 | CA2 (0.54) | APPCA12CA1CA2CA7 | |
| SCHEMBL482383 | 0.80 | CA2 (0.41) | APPCA12CA1CA2CA7 | |
| SCHEMBL4307124 | 0.80 | ALDH1A1 (0.54) | GRM4CYP3A4TSHRLMNAMAPT | |
| SCHEMBL30958058 | 0.78 | ACHE (0.39) | APPCA12CA1CA2CA7 | |
| SCHEMBL29445512 | 0.78 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9937350 | 0.78 | ACHE (0.62) | CYP1A2CYP3A4ACHEMAPTNPSR1 | |
| SCHEMBL388185 | 0.78 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4026631 | 0.78 | ACHE (0.39) | APPCA12CA1CA2CA7 | |
| SCHEMBL629513 | 0.76 | MAPT (0.46) | GRM4CA2CA4HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230359119-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| WO-2022063106-A1 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | BEIGENE, LTD. (KY) | 2022-03-31 | — | — | WO | disclosed |
| US-11034840-B2 | Water-soluble polymeric dyes | BECTON, DICKINSON AND COMPANY (US) | 2021-06-15 | — | — | US | disclosed |
| WO-2021067313-A1 | EUKARYOTIC SEMI-SYNTHETIC ORGANISMS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020163532-A1 | IL-2 CONJUGATES AND METHODS OF USE THEREOF | Synthorx, Inc. (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20200062966-A1 | Water-Soluble Polymeric Dyes | BECTON, DICKINSON AND COMPANY | 2020-02-27 | — | — | US | disclosed |
| US-8293905-B2 | Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8236920-B2 | Polyarylene and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-07 | — | — | US | disclosed |
| EP-1995265-B1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-08-01 | — | — | EP | disclosed |
| EP-1935916-B1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-05-23 | — | — | EP | disclosed |
| US-20100105786-A1 | Method for Producing Polymer Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-2172470-A1 | BIPYRIDINE COMPOUND, TRANSITION METAL COMPLEX, AND METHOD FOR PRODUCTION OF CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20090253015-A1 | POLYARYLENE BLOCK COPOLYMER AND USE THEREOF | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090036632-A1 | Polyarylene and Process for Producing the Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-05 | — | — | US | disclosed |
| EP-1995265-A1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080287646-A1 | Polyarylene and Method for Producing the Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-11-20 | — | — | US | disclosed |
| EP-1935916-A1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1857482-A1 | POLYARYLENE BLOCK COPOLYMER AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2007-11-21 | — | — | EP | disclosed |
| CN-1922236-A | Method for producing polymer compound | SUMITOMO CHEMICAL CO (JP) | 2007-02-28 | — | — | CN | disclosed |
| EP-1721922-A1 | METHOD FOR PRODUCING POLYMER COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036632-A1 | Polyarylene and Process for Producing the Same | CYP1A1, CYP1B1, C1R | APP 1378/4885GRM4 3987/4885CA12 2431/4885 |
| US-20080287646-A1 | Polyarylene and Method for Producing the Same | CYP1A1, C1R, CBR1 | APP 1488/4885GRM4 1756/4885CA12 1313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.